Analysis of Genome Operating Systems for Immune Network by Polycomb Group Genes.

通过 Polycomb 组基因分析免疫网络的基因组操作系统。

基本信息

  • 批准号:
    12490025
  • 负责人:
  • 金额:
    $ 9.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

The Polycomb group (PcG) genes products form protein complexes in mammalian cell nuclei that contribute to maintain chromatin silencing of target genes. Among mammalian PcG homologues, mel-18 has been elucidated to regulate cell cycle progression, cell death, or senescence through analyses of knockout/Tg mice. Its product participatesin Polycomb protein complexes, whose existences in cell nuclei are displayed speckled distributions, overlapped with heterochromatin areas in immunohistochemical examinations.We describe that the defect in thymic T-lymphocyte development of mel-18 deficient mice implies the involvement of mel-18 in the maintenance of immature lymphocyte by regulating their survival via controlling the expression of some commitment and survival factors including subgroup of bcl-2 family. Therefore we would like to propose our results as the regulation mechanisms to control the balance between proliferation and cell death in lymphocyte development, especially ETP cell of DN1 fraction and small cell (E cell) of DN3 fraction just before the beta-selection of immature thymocyte by destabilization of chromatin silencing Polycomb protein complex.
Polycomb 组 (PcG) 基因产物在哺乳动物细胞核中形成蛋白质复合物,有助于维持靶基因的染色质沉默。在哺乳动物 PcG 同系物中,通过对基因敲除/Tg 小鼠的分析,已阐明 mel-18 可以调节细胞周期进程、细胞死亡或衰老。其产物参与Polycomb蛋白复合物,其在细胞核中呈斑点状分布,在免疫组化检查中与异染色质区域重叠。我们描述mel-18缺陷小鼠胸腺T淋巴细胞发育缺陷提示mel-18通过控制某些淋巴细胞的表达来调节淋巴细胞的存活,从而参与维持未成熟淋巴细胞的生存。 承诺和生存因素,包括 bcl-2 家族亚组。因此,我们希望提出我们的结果作为控制淋巴细胞发育中增殖和细胞死亡之间平衡的调节机制,特别是在通过染色质沉默Polycomb蛋白复合物的不稳定对未成熟胸腺细胞进行β选择之前的DN1级分的ETP细胞和DN3级分的小细胞(E细胞)。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakai R, Kajiume T, Inoue H, Kanno R, Miyazaki M, Ninomiya Y, and Kanno M.: "TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells."Toxicol. Sci.. 72. 84-91 (2003)
Sakai R、Kajiume T、Inoue H、Kanno R、Miyazaki M、Ninomiya Y 和 Kanno M.:“TCDD 治疗消除了造血干细胞的长期重建活性。”Toxicol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujisaki S, Ninomiya Y, Ishihara H, Miyazaki M, Kanno R, Asahara T, and Kanno M.: "Dimerization of the Polycomb-group protein Mel-18 is regulated by PKC phosphoryjation."BBRC. 300. 135-140 (2003)
Fujisaki S、Ninomiya Y、Ishihara H、Miyazaki M、Kanno R、Asahara T 和 Kanno M.:“多梳蛋白 Mel-18 的二聚化受 PKC 磷酸化的调节。”BBRC。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamasaki, M., Sasho, S., Moriya, H., Kanno, M., Harada, M., Kamada, N., Shimizu, E., Nakayama, T., Taniguchi, M: "Extrathymic development of Vall T cells in placenta during pregnancy and their possible physiological role"J.Immunology. 166. 7244-7249 (2001
Yamasaki, M.、Sasho, S.、Moriya, H.、Kanno, M.、Harada, M.、Kamada, N.、Shimizu, E.、Nakayama, T.、Taniguchi, M:“Vall T 的胸腺外发育
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujisaki S: "Dimerization of the Polycomb-group protein Mel-18 is regulated by PKC phosphorylation"BBRC. 300. 135-140 (2003)
Fujisaki S:“多梳蛋白 Mel-18 的二聚化受 PKC 磷酸化的调节”BBRC。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyazaki, K., Inoue, H., Onai, N., Ishihara, H., Kanno, M.: "Chemokine-mediated thymopoiesis is regulated by a mammalian Polycomb group gene, mel-18"Immunol Lett.. 80. 139-143 (2002)
Miyazaki, K.、Inoue, H.、Onai, N.、Ishihara, H.、Kanno, M.:“趋化因子介导的胸腺生成受哺乳动物 Polycomb 组基因 mel-18 调节”Immunol Lett.. 80. 139
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANNO Masamoto其他文献

Identification of DAMPs in mother’s milk of a cohort study on atopic dermatitis in breastfed infants; part 2: In vitro analysis of mechanisms of NLRP3 inflammasome activation by saturated fatty acids
母乳喂养婴儿特应性皮炎队列研究母乳中 DAMP 的鉴定;第 2 部分:饱和脂肪酸激活 NLRP3 炎症小体机制的体外分析
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    INOUE Hiroko. KONG Weng Sheng; GUO Yun;SHIMOJO Naoki;KANNO Masamoto
  • 通讯作者:
    KANNO Masamoto
Identification of DAMPs in mother’s milk of a cohort study on atopic dermatitis in breastfed infants ; part 1: In vivo study of skin and gut of breastfed HR-1 mice
母乳喂养婴儿特应性皮炎队列研究中 DAMP 的鉴定第 1 部分:母乳喂养 HR-1 小鼠皮肤和肠道的体内研究
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    KONG Weng Sheng;INOUE Hiroko;GUO Yun;SHIMOJO Naoki;KANNO Masamoto
  • 通讯作者:
    KANNO Masamoto

KANNO Masamoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANNO Masamoto', 18)}}的其他基金

Long-chain fatty acids are associated with the pathogenesis of atopic dermatitis via induction of inflammatory ILC3s
长链脂肪酸通过诱导炎症 ILC3 与特应性皮炎的发病机制相关
  • 批准号:
    19K07609
  • 财政年份:
    2019
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Epigenetic regulation of primary lymphoid organ microenvironment
原发性淋巴器官微环境的表观遗传调控
  • 批准号:
    23616003
  • 财政年份:
    2011
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Destabilization of RAG proteins and cell cycle regulation by Polycomb group genes
Polycomb 组基因导致 RAG 蛋白不稳定和细胞周期调节
  • 批准号:
    09670330
  • 财政年份:
    1997
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the new nuclear factor mel-18 which affects the development and signaltransduction of B cells
影响B细胞发育和信号转导的新核因子mel-18分析
  • 批准号:
    07670365
  • 财政年份:
    1995
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of enhancer/silencer regions of TCR gene
TCR基因增强子/沉默子区域分析
  • 批准号:
    05670293
  • 财政年份:
    1993
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 9.09万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 9.09万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了